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Background
Cancer of the colon and rectum (colorectal cancer, CRC) is one of 
the most common cancer diseases worldwide and remains the sec-
ond most common cause of cancer death in Western countries [1]. 
Approximately one in every 4 patients with CRC will have dissemi-
nated disease at the time of diagnosis and the majority of these pa-
tients have synchronous liver metastases (20 %). During the course 
of the disease, approximately 50 % of all CRC patients will develop 
liver metastases, but only 10–25 % of these patients may be cured 
by liver surgery and perioperative chemotherapy [1–3]. From a clin-
ical point of view, it is important to know the exact extent of the 
disease prior to surgery. However, despite significant improve-
ments in preoperative staging procedures (e. g., contrast-enhanced 
ultrasound (CE-US), multi-slice contrast-enhanced computed to-
mography (CE-CT), contrast-enhanced magnetic resonance imag-
ing (MRI), and positron emission tomography CT (PET-CT)), stud-
ies suggest that 10–30 % of patients have unrecognized hepatic 
metastases diagnosed during primary surgery for CRC [4–6]. Dur-
ing open CRC surgery, the surgeon performs manual palpation of 
the liver and this evaluation may be supplemented with intraoper-
ative ultrasonography (IOUS) and contrast-enhanced IOUS (CE-
IOUS). IOUS has been considered the “gold standard” in open sur-
gery for CRC since the late 1980s, as IOUS may detect liver metas-
tases, which can neither be palpated nor detected during 
preoperative imaging [7–11]. Today the majority of CRC operations 
are performed as a laparoscopic procedure and this appears to be 
equivalent to open surgery regarding perioperative morbidity, 
mortality and oncological outcome (radical resection, recurrence 
rates, and long-term survival) [12–16]. The laparoscopic approach 
precludes palpation of the liver, but a systematic examination of 
the liver by laparoscopic inspection (LAP) and use of laparoscopic 
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Abstr Act
Colorectal cancer (CRC) is one of the most common cancer diseases 
worldwide. One in 4 patients with CRC will have a disseminated disease 
at the time of diagnosis and often in the form of synchronous liver me-
tastases. Studies suggest that up to 30 % of patients have non-recog-
nized hepatic metastases during primary surgery for CRC. Intraoperative 
ultrasonography examination (IOUS) of the liver to detect liver metas-
tases was considered the gold standard during open CRC surgery. Today 
laparoscopic surgery is the standard procedure, but laparoscopic ultra-
sound examination (LUS) is not performed routinely.
Aim To perform a systematic review of the test performance of IOUS 
and LUS regarding the detection of synchronous liver metastases in 
patients undergoing surgery for primary CRC.
Method The literature was systematically reviewed using the search 
engines: PubMed, Cochrane, Embase and Google. 21 studies were in-
cluded in the review and the key words: intraoperative ultrasound, lap-
aroscopic ultrasound, staging colon and rectum cancer.
Results Intraoperative ultrasound showed a higher sensitivity, specific-
ity, positive predictive value and overall accuracy for the detection liver 
metastases during surgery for primary CRC, compared to preoperative 
imaging modalities (ultrasound, computed tomography (CT) and con-
trast-enhanced computed tomography (CE-CT)). LUS showed a higher 
detection rate for liver metastases compared to CT, CE-CT and magnet-
ic resonance imaging (MRI).
Conclusion This systematic review found that both IOUS and LUS had 
a higher detection rate regarding liver metastases during primary CRC 
surgery, especially liver metastases < 10 mm in diameter, when com-
pared to US, CT, CE-CT and MRI.
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ultrasound (LUS) may be used as an alternative to digital palpation 
and traditional IOUS. Although dedicated probes for LUS have been 
commercially available for more than 15 years, LUS examination of 
the liver during laparoscopic resection for CRC is not performed 
routinely [12]. In order to assess whether standard preoperative 
imaging provides accurate and sufficient information regarding the 
presence of liver metastases in patients scheduled for (laparoscop-
ic) CRC surgery, it is relevant to perform a systematic review of the 
present IOUS and LUS literature.
Aim
The aim of this study was to perform a systematic review of the test 
performance of IOUS and LUS regarding the detection of (unrec-
ognized) synchronous liver metastases in patients undergoing pri-
mary colorectal cancer surgery.
Method
Literature search
A systematic electronic literature search was conducted through 
PubMed, Cochrane Library, EMBASE and Google Scholar and ended 
on the February 1, 2016. The following keywords were used: intra-
operative ultrasound, laparoscopic ultrasound, colon cancer, rec-
tum cancer, staging colon and rectum cancer, TNM staging. A sec-
ondary search was performed by manually checking the referenc-
es listed in the included studies.
Eligibility criteria
English-language articles published after 1980 and containing only 
data on primary resection for CRC were included. The included 
studies were required to have a defined gold standard (i. e., histo-
logical confirmation and/or clinical follow-up). Clinical follow-up 
was defined as the use of postoperative imaging modalities (US, 
CT, CE-CT or MRI) with 3–6-month scanning intervals.
Data collection and review
A predefined form was used for data extraction and recording. The 
outcome data included publication year, study design, number of 
patients, preoperative investigation, number of liver lesions, num-
ber of patients with liver metastases, changes in treatment strate-
gy due to IOUS/LUS, and follow-up. Clinical impact was defined as 
changes in the initial treatment strategy as a result of the intraop-
erative ultrasound findings.
The test performance (sensitivity, specificity, positive predictive 
value (PPV) and negative predictive value (NPV)) of IOUS and LAP/
LUS was recorded, as was the test performance of preoperative im-
aging modalities when available. The results of LAP alone were not 
reported since LUS will always include a laparoscopic inspection of 
the liver surface. Potential changes in treatment strategy due to 
IOUS/LUS findings were also noted, and a comparison with preop-
erative imaging modalities was performed when available.
Preoperative imaging techniques have improved during the in-
clusion period, and the use of multi-slice contrast-enhanced CT, MRI 
and PET has made conventional transabdominal ultrasound (US) re-
dundant. We assume that this improved imaging would have a pos-
itive impact on test performance during the last decade of the in-
clusion period, and therefore we decided to divide the inclusion pe-
riod into 2 periods; Period 1 (studies published before the January 
1, 2005) and period 2 (studies published after the January 1, 2005).
2 authors (SBE and CWF) independently screened all potential 
abstracts, selected the relevant studies and performed the analy-
ses. Disagreements were resolved by a third party (MBM) or by con-
sensus. The included studies were evaluated according to the 
GRADE guidelines [17].
Results
A total of 1 677 publications were identified, but only 323 abstracts 
proved potentially relevant and were read. 89 articles were re-
trieved for detailed evaluation and assessment of the reference list 
(▶Fig. 1). According to the inclusion criteria, 21 studies were in-
cluded in the final review (▶table 1).
Study grading and design
18 studies were prospective and 3 were retrospective. The overall 
study grading was very low. 16 articles (76 %) were graded very low 
and 5 articles (24 %) low. 15 studies were from period 1 and 6 from 
period 2 [6, 18–37]. A comparison with preoperative imaging was 
performed in 20 studies, whereas the impact of IOUS/LUS on treat-
ment strategy was reported in 7 trials. The total number of includ-
ed patients was 2 457, and the included number of patients varied 
between 13 and 388. The majority of studies had histological con-
firmation as the gold standard (n = 17) and 15 studies also includ-
ed imaging based on postoperative follow-up for up to 6 months 
(▶table 1). 4 studies had a blinded design (25, 27, 32, 34). In 19 
studies, some of the included patients had known synchronous 
liver metastases at the time of primary CRC surgery (6, 18–32, 34–
36). 2 studies evaluated IOUS/LUS in patients without known syn-
chronous liver metastases (33, 37).
Intraoperative ultrasound (IOUS)
14 studies evaluated the test performance of IOUS in the detection 
of synchronous colorectal liver metastases during open CRC sur-
gery; 10 studies from period 1 and 4 from period 2 (6, 18–25, 27–
28, 33–34, 36).
Per lesion analysis
6 studies compared the test performance of IOUS to intraoperative 
palpation and preoperative imaging modalities in a per lesion anal-
ysis (19–22, 25, 34). In 4 studies IOUS showed a significantly high-
er sensitivity and a higher specificity (90–98 % and 94–98 %, respec-
tively) compared to preoperative imaging (US, CT and CE-CT) in 
studies from period 1 (19–22, 25) (▶table 2). The sensitivity and 
specificity were not calculated in the only study from period 2, but 
IOUS detected more liver metastases when compared to preoper-
ative US and CE-CT (34).
The PPV and NPV of IOUS were evaluated in 2 studies from pe-
riod 1 and they found a significantly higher PPV and NPV (92 % and 
95–98 %, respectively) compared to US, CT and CE-CT (19, 21) 
(▶table 2). The overall accuracy for IOUS was approximately 95 % 
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and this was significantly higher compared to US, CT and CT-CT in 
the studies from period 1 (19, 21).
IOUS detected between 32 and 57 % additional liver metastases 
compared to preoperative imaging in all studies in both periods 
(19–22, 25, 34) (▶table 2).
Per patient analysis
8 studies compared the test performance of IOUS to the preoper-
ative imaging modalities in a per patient analysis (6, 18, 23, 24, 27, 
28, 33, 36) (▶table 3). IOUS showed a higher sensitivity and high-
er specificity (96–100 % and 98–100 %, respectively) compared 
to preoperative imaging (US and CE-CT) in the studies from both 
periods. In 2 of the studies IOUS showed a significantly higher sen-
sitivity compared to preoperative US (6, 27). One study found the 
sensitivity of IOUS inferior compared to CE-CT (28) IOUS detected 
more patients with liver metastases when compared to preopera-
tive US, CT and CE-CT (33, 36).
The PPV and NPV of IOUS were evaluated in 4 studies and a high-
er PPV and NPV (90–100 % and 89–100 %) compared to US and 
CE-CT were observed (6, 24, 27, 28) (▶table 3).
The overall accuracy for IOUS was 98 % and this was higher com-
pared to US and CT-CT (6, 24, 27). One study showed a significant-
ly higher overall accuracy compared to US (27) (▶table 3). From 
period 1, IOUS detected up to 9 % additional patients with liver me-
tastases compared to US, CT and CE-CT imaging in the studies (6, 
18, 23, 24). One IOUS study did not find additional patients with 
liver metastases (28). In the studies from period 2, IOUS detected 
additional patients with liver metastases upto 14 % of cases com-
pared to preoperative US, CT and CE-CT imaging (27, 33, 36) 
(▶table 3).
Overall, 5 studies from period 1 found a significantly higher sen-
sitivity of IOUS (range 90–100 %) compared to preoperative imag-
ing (range 41–91 %) (6, 19, 21, 22, 25).
3 studies found a significantly higher overall accuracy when 
comparing IOUS (94–99 %) to US (74–97 %), CT (75 %) and CE-CT 
(74 %) (19, 21, 27). Only one of the more recent studies (period 2) 
reported on the sensitivity, specificity, PPV, NPV and overall accu-
racy and found IOUS superior compared to preoperative US (27).
One small, prospective trial reported the results of contrast-en-
hanced IOUS (CE-IOUS) using the microbubble agent SonoVue® 
Potentially relevant abstracts
n=1677
Excluded abstracts (n =1354)
Not relevant by title
Reviewed abstracts
n=323
Reviewed full-text articles
n=89
Articles included for analysis
n=21
Full-text articles excluded from the review
(n =68)
Did not meet the inclusion criteria
Excluded abstracts (n =234)
Not relevant based on detailed
evaluation of the abstract
▶Fig. 1 Flow diagram of study selection for the systematic review.
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and CE-IOUS provided a change in the diagnosis of the liver lesions 
in 20 % of cases (36).
In both periods the treatment plan was changed to less exten-
sive surgery or oncological therapy in 10–17 % of the patients due 
to the IOUS findings (22, 24, 25, 27, 34, 36).
Laparoscopic ultrasound (LUS)
7 studies reported on the use of LUS in the detection of synchro-
nous liver metastases during laparoscopic surgery of primary CRC 
(26, 29–32, 35, 37). 5 studies were from period 1 and 2 studies 
from period 2 (26, 29–32, 35, 37) (▶table 4). Only one trial eval-
uated LUS in patients without known liver metastases (37). In 6 tri-
als the findings of the preoperative imaging modalities (US, CT, 
CE-CT and MRI) were compared to LUS findings (26, 29, 31, 32, 
35,37).
Per lesions analysis
Only studies from period 1 included per lesion analyses. 2 studies 
compared the test performance of LUS to preoperative imaging 
modalities and one study to IOUS in per lesion analyses (26, 30, 32). 
The sensitivity and specificity for LUS were evaluated in one study 
and were 80 and 91 %, respectively (30). The sensitivity and speci-
ficity were not calculated in the other studies, but LUS detected 
from 2 to 13 % additional liver metastases when compared to pre-
operative CE-CT (26, 32).
Per patient analysis
4 studies compared the test performance of LUS in per patient anal-
yses (29, 31, 35, 37). Of these, one study found LUS to have a high-
er sensitivity, specificity and overall accuracy (100, 100 and 100 %, 
respectively) compared to preoperative CE-CT (63, 96 and 88 %, 
▶table 1  Characteristics of included studies on IOUS and LUS (n = 19) and contrast-enhanced IOUS and LUS (n = 2).
study Year Design Preoperative 
investigation
Patients
n
Histological 
confirmation
Follow- up  * Grading
Period 1 (studies published before January 1, 2005)
Boldrinil [18] 1987 Prospectivea US/CT 86 Yes No  + ooo
Machi al [19] 1987 Prospectivea US/CE-CT 84 * * Yes Yes  + ooo
Olsen A.K [20] 1990 Prospectivea US 213 Yes Yes  + ooo
Machi al [21] 1991 Prospectivea US/CT 189 Yes Yes  + ooo
Stadler [22] 1991 Prospectivea US/CE-CT 85 Yes No  + ooo
Stewart [23] 1993 Prospectivea US/CE-CT 100 Yes Yes  + ooo
Paul [24] 1994 Prospectivea US/CE-CT 122 Yes Yes  + + oo
Rafaelsen [25] 1994 Prospective, blindeda US 295 Yes Yes  + ooo
Takeuchi [6] 1995 Prospectivea US 119 Yes Yes  + + oo
Marchesa [26] 1996 Prospectiveb CE-CT 22 Yes No  + ooo
Carter [28] 1996 Prospectivea US/CE-CT 73 Yes Yes  + ooo
Goletti [29] 1998 Prospectiveb US/CE-CT 33 Yes No  + ooo
Foley [30] 1998 Prospectiveb - 13 Yes No oooo
Hartley [31] 2000 Prospectiveb US/MRI 76 No Yes  + + oo
Milsom [32] 2000 Prospective, blindedb CE-CT 77 No Yes  + ooo
Period 2 (Studies published after January 1, 2005)
Study Year Design Preoperative 
investigation
Patients
N
Histological 
confirmation
Follow- up  * Grading
Agrawal [33] 2006 Retrospectivea US/CT 76 Yes Yes  + ooo
Kulig [27] 2007 Retrospective, blindeda US 388 Yes Yes  + ooo
Mazzoni [34] 2007 Prospective, blindeda US/CE-CT 167 Yes Yes  + ooo
Skrovina [35] 2008 Prospectiveb US/CE-CT/MRI/PET 70 Yes No  + + oo
 Shah [36] 2010 Prospectivec CE-CT 21 No Yes  + ooo
Itabashi [37] 2014 Retrospectived CE-CT/MRI 148 Yes Yes  + + oo
Total 2 457
 *  Follow-up: Postoperative scans (UL, CT, CE-CT or MRI) after 3–6 months
 * *  8 of the 84 patients had metachronous liver metastases
Underline: Trial with CRC patients without known synchronous liver metastases on preoperative imaging
a: Intraoperative ultrasound (IOUS), b: Laparoscopic ultrasound (LUS), c: Contrast-enhanced IOUS, d: Contrast-enhanced LUS
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respectively) (29). The sensitivity, specificity and overall accuracy 
were not calculated in the other 2 studies from period 2, but LUS 
detected from 3 to 11 % additional patients with liver metastases 
compared to US, CE-CT and MRI (35, 37) (▶table 4).
Neither p-values regarding the comparison of LUS and preop-
erative findings nor the PPV or NPV was reported in any of the  trials.
One trial used contrast-enhanced LUS (CE-LUS) with a micro-bub-
ble agent (Sonozoid®) and CE-LUS detected metastases not seen on 
the preoperative imaging modalities (CE-CT and MRI) [37].
One trial from period 1 evaluated the change in treatment plan 
(i. e., resectability of liver metastases) based on the additional find-
ings of LUS, and LUS led to a change in 12 % of the patients [29].
Discussion
Detection of synchronous liver metastases with IOUS 
during primary CRC surgery
The majority of the trials were from period 1, and IOUS was mostly 
compared to preoperative ultrasound (6, 18–25, 27, 28). 6 trials 
showed a significant difference in sensitivity, PPV, NPV and overall 
accuracy in favor of IOUS regarding the detection of additional liver 
metastases when compared to preoperative ultrasound (6, 19, 21, 
22, 25, 27). IOUS also had a higher specificity compared to preop-
erative ultrasound, but this was not statistically significant.
The trials included in this review span a very large time period, 
which led to the fact that many of them utilized quite poor compar-
ators. This was particularly evident in the studies of period 1. There-
fore, the comparison of preoperative ultrasound and non-con-
trast-enhanced CT has become obsolete. Many of the trials in this 
review use these outdated preoperative imaging modalities (US and 
non-contrast CT), and CT scans nowadays are more sensitive when 
performed as multi-slice, multi-phase contrast-enhanced imaging. 
The current recommendation for preoperative imaging for CRC is 
CE-CT due to its better sensitivity and specificity compared to 
transabdominal ultrasound (1, 39, 40).
2 studies from the same institution showed that IOUS had a sig-
nificantly better test performance than preoperative CT and CE-CT 
[19, 21]. Other trials showed the same trend regarding the number 
of additional detected liver metastases, but there was no informa-
tion regarding p-values (23, 24). Only 1 of the 14 trials showed IOUS 
to be inferior to CE-CT [28], but there was no obvious explanation 
for this observation. The reported poor sensitivity and specificity 
of CT and CE-CT in studies from the early period were probably due 
to the fact that these scans were performed without contrast 
agents or with a CE-CT slice thickness of 8–10 mm (18, 19, 21, 23, 
24). However, a similarly poor sensitivity was also noted in studies 
published more recently (34).
When comparing the 2 periods, IOUS detected 44 % additional 
liver metastases (“per lesion analysis”) in period 2 compared to 
32–52 % in the trials from period 1. Looking at the “per patient anal-
ysis”, there were a higher number of additional patients with liver 
metastases found (up to 14 %) in the trials from period 2 compared 
to the trials from period 1 (up to 9 %), even though preoperative US 
or (non-contrast) CT was the preferred standard in the latter peri-
od. It is important to note that despite the time-dependent im-
▶table 2 Test performance of IOUS and preoperative imaging modalities of the liver in open CRC surgery; based on per lesion analysis.
study Modality sensitivity ( %) Specificity 
( %)
PPV ( %) NPV ( %) Overall 
accuracy ( %)
Number of 
detected 
metastases
Additional 
metastases 
detected only 
by IOUs ( %)
Studies before 2005 (period 1)
Machi [19] 
n = 84
IOUS
US
CE-CT
97.8 p < 0.01a
41.3
47.8
94.0
95.5
92.5
91.8
86.4
81.5
98.4 p < 0.01a
70.3
72.1
95.4 p < 0.01a
73.5
74.3
45
19
22
51
Olsen A.K. [20] 
n = 213
IOUS
US
98.3
66.1
354
238
33
Machi [21] 
n = 189
IOUS
US
CT
93.3 p < 0.001a
41.3
47.1
94.7
96.7
94.1
92.4 p < 0.001a
89.6
84.5
95.4 p < 0.05a
70.9
72.2
94.1 p < 0.001a
74.2
75.0
97
43
49
50
Stadler [22] 
n = 85
IOUS
US/CE-CT
89.9 p < 0.001a
48.5
98.3
93.3
62
27
57
Rafaelsen [25] 
n = 295
IOUS
US
94.1 p < 0.0001a
63.7
97.8
92.0
192
130
32
Study after 2005 (period 2)
Mazzoni [34] 
n = 167
IOUS
US
CE-CT
–
56
49
–
94
92
84
47
41
44
n: number of patients included in the study
a: IOUS versus preoperative imaging modalities
PPV: positive predictive value; NPV: negative predictive value
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provements in CE-CT, the detection of liver metastases less than 
10 mm in diameter seems to remain a challenge [6, 23–25, 34].
The low number of publications (n = 4) in period 2 is a limit with 
respect to more exact conclusions regarding modern IOUS, but this 
observation probably just illustrates the widespread use of laparo-
scopic surgery in the treatment of CRC within this period.
Contrast-enhanced IOUS (CE-IOUS) increases the sensitivity for 
detecting liver metastases during liver surgery [38, 39], but only 
one trial using CE-IOUS during primary CRC resection was identi-
fied (36). The trial reported a change in the diagnosis of the liver 
lesions in 20 % of cases, but only one malignant additional liver le-
sion was detected by CE-IOUS when compared to IOUS. Since only 
21 patients were included, no firm conclusion can be drawn. There 
was a tendency towards CE-IOUS providing a higher sensitivity and 
specificity than non-contrast-enhanced IOUS, but there is a need 
for larger and controlled trials.
Detection of synchronous liver metastases with LUS 
during primary CRC surgery
Only 7 trials dealing with LUS as a screening modality for synchro-
nous liver metastases during primary laparoscopic resection for 
colorectal cancer were found: 5 studies from period 1 and 2 from 
period 2 (26, 29–32, 35, 37). In the trials from period 1, up to 9 % 
additional patients with liver metastases were found during LUS 
(29, 31). This was comparable to the results from period 2, where 
up to 11 % additional patients were detected (35, 37).
The higher number of additional patients with liver metastases 
found in period 2 than in period 1 could be related to the fact that 
in period 1 most studies already included patients with some me-
tastases. Hence, there were not many additional patients with me-
tastases to be found, whereas the studies in period 2 also investi-
gated series of patients starting with no apparent lesions, so that 
it was more likely to find additional patients with a few metastases.
In both periods, LUS detected more patients with liver metas-
tases (“per patient” analysis) compared to the preoperative CE-CT 
and MRI scans. No “per lesion” analyses were found in the trials 
from period 2, but in a recently published meta-analysis MRI has 
an overall sensitivity of 78–86 % and a specificity of 87 % for detect-
ing liver metastases in a “per lesion” analysis [40, 41]. Contrast-en-
hanced MRI with liver-specific contrast agents has a significantly 
higher sensitivity regarding the detection of liver metastases than 
CE-CT and PET/CT, but not to IOUS [5, 41]. This corresponds well 
▶table 3 Test performance of IOUS and preoperative imaging modalities of the liver in open CRC surgery; based on per patient analysis.
study Modality sensitivity ( %) Specificity 
( %)
PPV ( %) NPV ( %) Overall 
accuracy 
( %)
Number of 
patients with 
detected 
metastases
Additional patients 
with metastases 
detected only by 
IOUs ( %)
Studies before 2005 (period 1)
Paul [24] 
n = 122
IOUS
US
CE-CT
96
76
76
98
94
90
92
76
66
99
94
94
98
90
87
25
19
19
5
Carter [28] 
n = 73
IOUS
US
CE-CT
77
77
94
100
100
91
100
100
89
89
85
95
13
13
16
0
Takeuchi [6] 
n = 119
IOUS
US
100 p < 0.01
42
98
99
90
88
100
90
98
90
19
8
9
Boldrinil 
[18] 
n = 86
IOUS
US
CT
21
16
16
6
Stewart [23] 
n = 100
IOUS
US
CE-CT
16
10
11
5
Studies after 2005 (period 2)
Agrawal [33] 
n = 76
IOUS
US
CT
11
0
0
14
Kuling [27] 
n = 388
IOUS
US
99.1 p < 0.05
91.1
98.5 p > 0.05
98.5
99.1 p > 0.05
95.7
98.5 p > 0.05
96.8
98.9 p < 0.05
96.6
247
227
5
Shah [36] 
n = 21b
IOUS
CE-CT
4
1
14
n: number of patients included in the study
a: IOUS versus preoperative imaging modalities; b: contrast-enhanced IOUS
PPV: positive predictive value; NPV: negative predictive value
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with the LUS findings in the “per patient analysis”, which showed a 
higher detection rate for liver metastases compared to preopera-
tive MRI [31, 37].
PET/CT has an overall sensitivity of 66–86 % and a specificity of 
97 % in a “per-lesion” analysis for detecting colorectal liver metas-
tases [5, 40–42]. However, most of the studies evaluate changes in 
clinical management according to PET/CT rather than the diagnos-
tic performance. PET/CT has a higher sensitivity in detecting ex-
tra-peritoneal spread than CE-CT, but the exact role of PET/CT is 
still unclear due to the small number of studies [41, 43, 44]. The 
present literature search revealed no trials comparing the test per-
formance of PET/CT and intraoperative ultrasound during primary 
CRC surgery.
There were only 2 trials from period 1 assessing LUS in a “per le-
sion” analysis (26, 32). They found up to 13 % additional metasta-
ses compared to preoperative CE-CT. Contrast-enhanced LUS ex-
amination of the liver was only evaluated in one retrospective study 
suggesting an increased detection rate of liver metastases, but the 
results should be confirmed in larger prospective trials [37].
As seen with IOUS, LUS was especially effective in detecting liver 
metastases < 10 mm in diameter [29, 31, 32, 35, 37]. A standard ab-
dominal CE-CT scan has an overall sensitivity for detecting colorec-
tal liver metastasis of 74–83 % and a specificity of 59 % in a “per le-
sion” analysis, and for lesions under 10 mm the mean sensitivity 
drops to 47 % [40, 42, 45]. The mean sensitivity for detecting liver 
metastases < 10 mm is 60 % for MRI (40, 42). This relates to the high-
er detection rate of small liver metastases found during IOUS and 
LUS compared to preoperative imaging (CE-CT and MRI), but the 
fact that there is no delay between the examination (IOUS/LUS) and 
surgery may have had an impact on the results.
Both the “per lesion” and the “per patient” analyses are faced 
with potential bias problems. Most of the included trials used the 
“per lesion” analysis, and this may infer bias in favor of intraopera-
tive ultrasound (e. g., including patients with multiple liver metas-
tases will increase the probability of finding additional metastases). 
Using a “per patient” analysis may also cause problems, since this 
kind of analysis does not count the number of lesions, and there-
fore may underestimate the value of intraoperative ultrasound. In 
the present review, most of the included patients had known liver 
metastases at the time of surgery, and this may also have helped 
the IOUS/LUS evaluation. Overall, the lack of blinded trials was 
prominent in this review (n = 4, 19 %).
In almost half of the studies it was a radiologist with ultrasound 
expertise who performed IOUS, and this would undoubtedly in-
crease the sensitivity of the ultrasound examination [1, 6, 23–
26, 28, 32, 35, 36]. Therefore, it is unclear whether it would be pos-
sible to reproduce the same results in a clinical setting where the 
surgeon performs the ultrasound examination.
Clinical impact of IOUS and LUS during primary CRC 
resection
A clinical impact, defined as a change in initial treatment strategy, 
was reported in 7 trials (22, 24, 25, 27, 29, 34, 36). IOUS altered 
the surgical strategy or postoperative therapy in 10–15 % of the pa-
tients included in period 1 trials, and in 14–17 % of trials from pe-
riod 2 (22, 24, 25, 27, 34, 36). In the trial concerning CE-IOUS, the 
contrast-enhanced examination altered the diagnosis of the liver 
lesions in 20 % of the patients and altered treatment strategy in 
14 % (36). The change in the treatment strategy due to LUS was 
evaluated in one trial from 1998 and it showed a treatment change 
in 12 % of the patients (29). Although not directly comparable, 
these studies suggest that the clinical impact of IOUS and LUS re-
mains unchanged over time – even in light of more extensive liver 
resections being performed during the latest period. Again, the 
lack of prospective studies with clearly defined (impact) criteria and 
a gold standard makes it difficult to draw any firm conclusions.
Staging with laparoscopy and LUS during upper GI-tract cancer 
surgery is a well-established procedure especially in the assessment 
of the surgical treatment of colorectal liver metastases (CRLM) 
[46, 47]. Several large studies have shown a significantly higher de-
tection rate of CRLM using laparoscopy and LUS during CRLM sur-
gery compared to preoperative imaging modalities [46, 48–50]. 
Based on this data, it is somewhat surprising that laparoscopy and 
LUS have not gained the same momentum during the introduction 
▶table 4 Test performance of LUS and preoperative imaging modali-
ties of the liver in laparoscopic CRC surgery; based on per lesion and 
per patient analysis
Per lesion analysis
study Imaging 
modality
Number of 
detected 
metastases
Number of 
metastases 
detected only by 
LUs ( %)
Studies before 2005 (Period 1)
Foley [30] 
n = 13
LUS
IOUS
4 
5
0
Marchesa [26] 
n = 22
LUS
CE-CT
8
7
13
Milsom et al. 
[32]
n = 77
LUS
CE-CT
51
50
2
Per patient analysis
Study Imaging 
modality
Number of 
patients with 
detected 
metastases
Number of patients 
with metastases 
only detected by 
LUS ( %)
Studies before 2005 (period 1)
Goletti [29] 
n = 33
LUS
CE-CT
8
5
9
Hartley [31] 
n = 76
LUS
US
MRI
5
0
2
4
Studies after 2005 (period 2)
Skrovina [35] 
n = 70
LUS
CE-CT
14
6
11
Itabashi [37] a
n = 148
LUS + CE-
LUS
CE-CT
MRI
4
0
0
3
a and CE-LUS: contrast enhanced LUS
E66
Ellebæk SB et al. Intraoperative Ultrasound as a … Ultrasound International Open 2017; 3: E60–E68
of laparoscopic resection of primary CRC, and a prospective rand-
omized study evaluating the actual clinical impact of adding LUS 
to the standard evaluation program for these patients seems war-
ranted.
Limitations of this review
In this review some of the included trials used outdated preopera-
tive imaging modalities (especially in period 1) and reviews with 
such different comparators do not allow solid conclusions from a 
scientific point of view, although the results were quite clear.
3 retrospective studies were also included in the review, which 
is suboptimal, but the trials had a homogeneous patient popula-
tion and a controlled design.
The report of accuracy data in some studies was not optimal. In 
fact, IOUS/LUS tended to become their own reference standard for 
the ultimate number of lesions, because no information regarding 
follow-up was given in the articles. In the majority of the trials there 
was no information regarding neoadjuvant or adjuvant chemother-
apy, which could bias the true value of intraoperative ultrasound. 
In fact, if a lesion was missed but treated by chemotherapy, it would 
not manifest and the false-negative finding of intraoperative ultra-
sound was not demonstrated.
Conclusion
This systematic review showed that both IOUS and LUS had a high-
er detection rate regarding (unrecognized) synchronous liver me-
tastases during primary colorectal cancer surgery, especially small-
er liver metastases < 10 mm in diameter, when compared to US, CT, 
CE-CT and MRI. Contrast-enhanced IOUS and LUS showed a higher 
sensitivity and specificity for detecting liver metastases compared 
to non-enhanced IOUS and LUS. The majority of trials in this review 
were from period 1 (published before the January 1, 2005) and had 
an obsolete preoperative imaging evaluation for comparison. To 
assess the true value of intraoperative ultrasound, there is a need 
for larger, prospective controlled trials in a homogeneous patient 
population including optimal preoperative imaging and well-de-
fined clinical impact criteria and a gold standard.
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